Model-based analysis uncovers mutations altering autophagy selectivity in human cancer

Zhu Han,Weizhi Zhang,Wanshan Ning,Chenwei Wang,Wankun Deng,Zhidan Li,Zehua Shang,Xiaofei Shen,Xiaohui Liu,Otto Baba,Tsuyoshi Morita,Lu Chen,Yu Xue,Da Jia
DOI: https://doi.org/10.1038/s41467-021-23539-5
2021-05-31
Abstract:Autophagy can selectively target protein aggregates, pathogens, and dysfunctional organelles for the lysosomal degradation. Aberrant regulation of autophagy promotes tumorigenesis, while it is far less clear whether and how tumor-specific alterations result in autophagic aberrance. To form a link between aberrant autophagy selectivity and human cancer, we establish a computational pipeline and prioritize 222 potential LIR (LC3-interacting region) motif-associated mutations (LAMs) in 148 proteins. We validate LAMs in multiple proteins including ATG4B, STBD1, EHMT2 and BRAF that impair their interactions with LC3 and autophagy activities. Using a combination of transcriptomic, metabolomic and additional experimental assays, we show that STBD1, a poorly-characterized protein, inhibits tumor growth via modulating glycogen autophagy, while a patient-derived W203C mutation on LIR abolishes its cancer inhibitory function. This work suggests that altered autophagy selectivity is a frequently-used mechanism by cancer cells to survive during various stresses, and provides a framework to discover additional autophagy-related pathways that influence carcinogenesis.
What problem does this paper attempt to address?